Estimating preferences for treatments in patients with localized prostate cancer

Mónica Ávila, Virginia Becerra, Ferran Guedea, José Francisco Suárez, Pablo Fernandez, Víctor Macías, Alfonso Mariño, Asuncion Hervas, Ismael Herruzo, María José Ortiz, Javier Ponce De León, Gemma Sancho, Oriol Cunillera, Yolanda Pardo, Francesc Cots, Montse Ferrer, Jordi Alonso, Olatz Garín, Angels Pont, Ana BoladerasFerran Ferrer, Evelyn Martínez, Joan Pera, Montse Ventura, Ferran Aguilo, Manel Castells, Humberto Villavicencio, Jordi Craven-Bratle, Belen De Paula, Benjamin Guix, Helena Hernandez, Víctor Muñoz, Alfredo Ramos, Pedro J. Prada

Research output: Contribution to journalArticleResearchpeer-review

14 Citations (Scopus)


© 2015 Elsevier Inc. Purpose: Studies of patients' preferences for localized prostate cancer treatments have assessed radical prostatectomy and external radiation therapy, but none of them has evaluated brachytherapy. The aim of our study was to assess the preferences and willingness to pay of patients with localized prostate cancer who had been treated with radical prostatectomy, external radiation therapy, or brachytherapy, and their related urinary, sexual, and bowel side effects. Methods and Materials: This was an observational, prospective cohort study with follow-up until 5 years after treatment. A total of 704 patients with low or intermediate risk localized prostate cancer were consecutively recruited from 2003 to 2005. The estimation of preferences was conducted using time trade-off, standard gamble, and willingness-to-pay methods. Side effects were measured with the Expanded Prostate Index Composite (EPIC), a prostate cancer-specific questionnaire. Tobit models were constructed to assess the impact of treatment and side effects on patients' preferences. Propensity score was applied to adjust for treatment selection bias. Results: Of the 580 patients reporting preferences, 165 were treated with radical prostatectomy, 152 with external radiation therapy, and 263 with brachytherapy. Both time trade-off and standard gamble results indicated that the preferences of patients treated with brachytherapy were 0.06 utilities higher than those treated with radical prostatectomy (P =.01). Similarly, willingness-to-pay responses showed a difference of €57/month (P =.004) between these 2 treatments. Severe urinary incontinence presented an independent impact on the preferences elicited (P<.05), whereas no significant differences were found by bowel and sexual side effects. Conclusions: Our findings indicate that urinary incontinence is the side effect with the highest impact on preferences and that brachytherapy and external radiation therapy are more valued than radical prostatectomy. These time trade-off and standard gamble preference assessments as well as the willingness-to-pay estimation could be useful to perform respectively cost-utility or cost-benefit analyses, which can guide health policy decisions.
Original languageEnglish
Pages (from-to)277-287
JournalInternational Journal of Radiation Oncology Biology Physics
Publication statusPublished - 1 Jan 2015


Dive into the research topics of 'Estimating preferences for treatments in patients with localized prostate cancer'. Together they form a unique fingerprint.

Cite this